Recent Advances in Diagnosis and Surgical Treatment of Pancreatic Cancer
Recent Advances in Diagnosis and Surgical Treatment of Pancreatic Cancer
复制标题
胰腺癌诊断和手术治疗的最新进展
DOI：
10.1007/978-4-431-68252-3_16
复制
发表时间：
1993
期刊：
影响因子：
--
通讯作者：
O. Ohashi
中科院分区：
文献类型：
--
作者：
S. Matsuno;M. Kobari;Y. Saitoh;O. Ohashi
本文综述了日本胰腺癌的诊断和手术治疗的最新进展。在1981 - 1990年期间，在日本胰腺学会（JPA）胰腺癌注册委员会收集并分析了11317例患者。3743例（33%）患者被切除。T1肿瘤小于2cm的患者435例（3.8%），诊断为i期肿瘤的患者274例（2.4%）。38%的T1期肿瘤和38%的i期肿瘤被US检测到。根据JPS分期的3年生存率和5年生存率，StageI为64%和46%，StageII为35%和28%，StagcIII为24%和20%，StageIV为12%和8%。
In the present study, we reviewed the recent advances in diagnosis and surgical treatment of pancreatic cancer in Japan. During the period from 1981 to 1990, 11317 patients were collected and analysed at registration commitee of pancreatic cancer in Japan Pancreas Society(JPA). 3743patients(33%) were resected. There were 435 patients(3.8%) with T1 tumors less than 2cm in size and the diagnosis of StageI tumors was made in 274(2.4%)patients. Thirty eight percent of T1 tumors and 38% of StageI tumors were detected by US. Three year survival and 5-year survival according to JPS staging were 64% and 46% in StageI, 35% and 28% in StageII, 24% and 20% in StagcIII,and 12% and 8% in StageIV respectively.